Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Cocktail & Poster Display session

95P - Anticancer activity of Inula recemosa root extract in human liver cancer cell line by attenuation of OCT4/Sox2 axis


06 Mar 2023


Cocktail & Poster Display session


Tania Ghosh(Sarkar)


Annals of Oncology (2023) 8 (1suppl_2): 100898-100898. 10.1016/esmoop/esmoop100898


T. Ghosh(Sarkar)1, A. Mukherjee2, B. Nag2, A. Ghosh1, S. Mondal3, R. Bhattacharyya1, S. Mukhopadhyay1

Author affiliations

  • 1 Molecular Biology, Netaji Subhas Chandra Bose Cancer Hospital, 700094 - Kolkata/IN
  • 2 Medical Dept., Bharati Vidyapeeth Medical College, 411 043 - Pune/IN
  • 3 Biochemistry, Netaji Subhas Chandra Bose Cancer Hospital, 700094 - Kolkata/IN


This content is available to ESMO members and event participants.

Abstract 95P


Hepatocellular carcinoma (HCC) has become one of the leading causes of death globally in males and is also rising in females at an alarming rate. The growth, oncogenicity, metastasis and therapeutic resistance of hepatocellular carcinoma is maintained by hepatic cancer stem cells (HCSCs). The development of new therapeutic approaches specifically targeting hepatic cancer stem cells using herbal medicine could propose new hope for advanced HCC treatment. To achieve therapeutic success, emphasis should also depend on inhibitors that would not only be more effective on tumors but have minimal normal tissue toxicity. Considering the hepatoprotective role of Inula recemosa suggested before, the aim of our present study was to understand the role of Inula recemosa root (IRE) on hepatocellular carcinoma, and hepatic cancer stemness.


The cytotoxicity effect of n-hexane extract of Inula recemosa was evaluated by MTT assay on HepG2 liver cancer and WRL68 liver normal cell lines. Colony formation was also performed to measure reproductive integrity after treating with different concentration over a prolonged period of time. Flowcytometry method was used for cell cycle analysis, apoptosis and the production of reactive oxygen species (ROS) by DCFDA. Effect of IRE on cancer stemness transcription factors like SOX 2 and OCT4 transcript level was determined by RT-PCR method. Immunocytochemistry method was used to check the change in cancer stemness marker protein expression after IRE treatment.


IRE showed very low toxicity on WRL68 normal liver cell line but robust antiproliferative effect on HepG2 cell line by induction of apoptosis. The induction of apoptosis was supported by increase in ROS production level in IRE treatment groups when compared with untreated cells. Cell cycle analysis showed arrest in Sub G0 phase. IRE also attenuated transcript level and protein expression of stemness markers.


Our data endorses the potential of IRE in hepatocellular carcinoma on targeting the cancer stem cell transcription factors for the first time. We can conclude that IRE might open up new therapeutic avenues on advanced therapies of hepatocellular carcinoma in near future.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.


Has not received any funding.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.